Search

Search Constraints

You searched for: Author/Creator Wallentin, Lars

Search Results

111. Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation. Issue 9 (16th September 2020)

112. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. Issue 2 (23rd December 2019)

113. Reduction in Overall Occurrences of Ischemic Events With Vorapaxar: Results From TRACER. Issue 4 (10th July 2014)

114. Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial. (1st March 2020)

115. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014. (19th September 2018)

116. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Issue 7 (July 2017)

117. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial. (February 2016)

118. Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial. Issue 6 (9th June 2017)

120. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. Issue 6 (June 2017)